Clinical characteristics of 82 cases of death from COVID-19.

A recently developed pneumonia caused by SARS-CoV-2 bursting in Wuhan, China, has quickly spread across the world. We report the clinical characteristics of 82 cases of death from COVID-19 in a single center. Clinical data on 82 death cases laboratory-confirmed as SARS-CoV-2 infection were obtained...

Full description

Bibliographic Details
Main Authors: Bicheng Zhang, Xiaoyang Zhou, Yanru Qiu, Yuxiao Song, Fan Feng, Jia Feng, Qibin Song, Qingzhu Jia, Jun Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0235458
id doaj-bf0364c3506e4de991bf703dd2863c16
record_format Article
spelling doaj-bf0364c3506e4de991bf703dd2863c162021-03-04T11:54:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01157e023545810.1371/journal.pone.0235458Clinical characteristics of 82 cases of death from COVID-19.Bicheng ZhangXiaoyang ZhouYanru QiuYuxiao SongFan FengJia FengQibin SongQingzhu JiaJun WangA recently developed pneumonia caused by SARS-CoV-2 bursting in Wuhan, China, has quickly spread across the world. We report the clinical characteristics of 82 cases of death from COVID-19 in a single center. Clinical data on 82 death cases laboratory-confirmed as SARS-CoV-2 infection were obtained from a Wuhan local hospital's electronic medical records according to previously designed standardized data collection forms. All patients were local residents of Wuhan, and a large proportion of them were diagnosed with severe illness when admitted. Due to the overwhelming of our system, a total of 14 patients (17.1%) were treated in the ICU, 83% of deaths never received Critical Care Support, only 40% had mechanical ventilation support despite 100% needing oxygen and the leading cause of death being pulmonary. Most of the patients who died were male (65.9%). More than half of the patients who died were older than 60 years (80.5%), and the median age was 72.5 years. The bulk of the patients who died had comorbidities (76.8%), including hypertension (56.1%), heart disease (20.7%), diabetes (18.3%), cerebrovascular disease (12.2%), and cancer (7.3%). Respiratory failure remained the leading cause of death (69.5%), followed by sepsis/MOF (28.0%), cardiac failure (14.6%), hemorrhage (6.1%), and renal failure (3.7%). Furthermore, respiratory, cardiac, hemorrhagic, hepatic, and renal damage were found in 100%, 89%, 80.5%, 78.0%, and 31.7% of patients, respectively. On admission, lymphopenia (89.2%), neutrophilia (74.3%), and thrombocytopenia (24.3%) were usually observed. Most patients had a high neutrophil-to-lymphocyte ratio of >5 (94.5%), high systemic immune-inflammation index of >500 (89.2%), and increased C-reactive protein (100%), lactate dehydrogenase (93.2%), and D-dimer (97.1%) levels. A high level of IL-6 (>10 pg/ml) was observed in all detected patients. The median time from initial symptoms to death was 15 days (IQR 11-20), and a significant association between aspartate aminotransferase (p = 0.002), alanine aminotransferase (p = 0.037) and time from initial symptoms to death was remarkably observed. Older males with comorbidities are more likely to develop severe disease and even die from SARS-CoV-2 infection. Respiratory failure is the main cause of COVID-19, but the virus itself and cytokine release syndrome-mediated damage to other organs, including cardiac, renal, hepatic, and hemorrhagic damage, should be taken seriously as well.https://doi.org/10.1371/journal.pone.0235458
collection DOAJ
language English
format Article
sources DOAJ
author Bicheng Zhang
Xiaoyang Zhou
Yanru Qiu
Yuxiao Song
Fan Feng
Jia Feng
Qibin Song
Qingzhu Jia
Jun Wang
spellingShingle Bicheng Zhang
Xiaoyang Zhou
Yanru Qiu
Yuxiao Song
Fan Feng
Jia Feng
Qibin Song
Qingzhu Jia
Jun Wang
Clinical characteristics of 82 cases of death from COVID-19.
PLoS ONE
author_facet Bicheng Zhang
Xiaoyang Zhou
Yanru Qiu
Yuxiao Song
Fan Feng
Jia Feng
Qibin Song
Qingzhu Jia
Jun Wang
author_sort Bicheng Zhang
title Clinical characteristics of 82 cases of death from COVID-19.
title_short Clinical characteristics of 82 cases of death from COVID-19.
title_full Clinical characteristics of 82 cases of death from COVID-19.
title_fullStr Clinical characteristics of 82 cases of death from COVID-19.
title_full_unstemmed Clinical characteristics of 82 cases of death from COVID-19.
title_sort clinical characteristics of 82 cases of death from covid-19.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description A recently developed pneumonia caused by SARS-CoV-2 bursting in Wuhan, China, has quickly spread across the world. We report the clinical characteristics of 82 cases of death from COVID-19 in a single center. Clinical data on 82 death cases laboratory-confirmed as SARS-CoV-2 infection were obtained from a Wuhan local hospital's electronic medical records according to previously designed standardized data collection forms. All patients were local residents of Wuhan, and a large proportion of them were diagnosed with severe illness when admitted. Due to the overwhelming of our system, a total of 14 patients (17.1%) were treated in the ICU, 83% of deaths never received Critical Care Support, only 40% had mechanical ventilation support despite 100% needing oxygen and the leading cause of death being pulmonary. Most of the patients who died were male (65.9%). More than half of the patients who died were older than 60 years (80.5%), and the median age was 72.5 years. The bulk of the patients who died had comorbidities (76.8%), including hypertension (56.1%), heart disease (20.7%), diabetes (18.3%), cerebrovascular disease (12.2%), and cancer (7.3%). Respiratory failure remained the leading cause of death (69.5%), followed by sepsis/MOF (28.0%), cardiac failure (14.6%), hemorrhage (6.1%), and renal failure (3.7%). Furthermore, respiratory, cardiac, hemorrhagic, hepatic, and renal damage were found in 100%, 89%, 80.5%, 78.0%, and 31.7% of patients, respectively. On admission, lymphopenia (89.2%), neutrophilia (74.3%), and thrombocytopenia (24.3%) were usually observed. Most patients had a high neutrophil-to-lymphocyte ratio of >5 (94.5%), high systemic immune-inflammation index of >500 (89.2%), and increased C-reactive protein (100%), lactate dehydrogenase (93.2%), and D-dimer (97.1%) levels. A high level of IL-6 (>10 pg/ml) was observed in all detected patients. The median time from initial symptoms to death was 15 days (IQR 11-20), and a significant association between aspartate aminotransferase (p = 0.002), alanine aminotransferase (p = 0.037) and time from initial symptoms to death was remarkably observed. Older males with comorbidities are more likely to develop severe disease and even die from SARS-CoV-2 infection. Respiratory failure is the main cause of COVID-19, but the virus itself and cytokine release syndrome-mediated damage to other organs, including cardiac, renal, hepatic, and hemorrhagic damage, should be taken seriously as well.
url https://doi.org/10.1371/journal.pone.0235458
work_keys_str_mv AT bichengzhang clinicalcharacteristicsof82casesofdeathfromcovid19
AT xiaoyangzhou clinicalcharacteristicsof82casesofdeathfromcovid19
AT yanruqiu clinicalcharacteristicsof82casesofdeathfromcovid19
AT yuxiaosong clinicalcharacteristicsof82casesofdeathfromcovid19
AT fanfeng clinicalcharacteristicsof82casesofdeathfromcovid19
AT jiafeng clinicalcharacteristicsof82casesofdeathfromcovid19
AT qibinsong clinicalcharacteristicsof82casesofdeathfromcovid19
AT qingzhujia clinicalcharacteristicsof82casesofdeathfromcovid19
AT junwang clinicalcharacteristicsof82casesofdeathfromcovid19
_version_ 1714803255273324544